FLT3 and NPM1 mutations in patients with Myeloid neoplasms

Mansoor, Mohammad Naem and Muhammad, Siti Aeshah @ Naznin and A. Talib, Norlelawati and Hamdan, Asmah Hanim and Abd. Aziz, Karimah Hanim and Ibrahim, Ismail and Ismail, Rusmawati (2021) FLT3 and NPM1 mutations in patients with Myeloid neoplasms. International Journal of Allied Health Sciences, 5 (1). p. 2118. E-ISSN 2600-8491

	PDF - Published Version Restricted to Registered users only until 8 April 2022. Download (115kB) | Request a copy
	PDF - Published Version Restricted to Repository staff only Download (115kB) | Request a copy

Abstract

Background: Acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN) are the most common entities of myeloid neoplasms. In AML, among the most frequent genetic alterations that carries both diagnostic and prognostic values are mutations in Nucleophosmin 1 (NPM1) and FMS-like tyrosine kinase 3 (FLT3) genes. Nevertheless, their frequencies among AML patients in Kuantan, Pahang have not been studied. Additionally, published literatures on both of these mutations in MPN are scarce although they have been shown to confer MPN in animal model. Purpose: This cross-sectional study therefore aimed to determine the proportion of FLT3-ITD, FLT3-D835 and NPM1 mutations among patients diagnosed with AML and MPN in Hospital Tengku Ampuan Afzan (HTAA) of Kuantan, Pahang from the year 2016 to 2019. Methodology: A total of 56 cases were studied, of which 43 cases were AML and 13 cases MPN. Molecular methods based on polymerase chain reaction were employed for mutation detection, from the retrieved trephine biopsy tissue blocks. Result: Six of the 43 cases (14.0%) of AML were positive for FLT3-ITD and a similar proportion (6/43, 14.0%) were also positive for NPM1 mutations. FLT3-D835 mutation was identified in three of the AML cases (7.0%) while concurrent mutations of NPM1 and FLT3-ITD were seen in 2 cases (4.7%). Two of 13 (15.4%) MPN cases were positive for FLT3-ITD. None of the MPNs cases were positive for either FLT-D835 or NPM1 mutations. Conclusion: The frequency of FLT3 and NPM1 mutations in the AML cases in our study were relatively lower as compared to other reports. The significance of FLT3-ITD mutation positivity found in our series of MPN remains to be elucidated.

Item Type:	Article (Meeting Abstract)
Uncontrolled Keywords:	Keywords: Acute Myeloid Leukemia, Myeloproliferative Neoplasms, FL3-ITD, FLT3-D835, NPM1
Subjects:	R Medicine > RB Pathology
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Medicine > Department of Community Medicine (Effective: 1st January 2011) Kulliyyah of Medicine > Department of Internal Medicine Kulliyyah of Medicine > Department of Pathology & Lab Medicine
Depositing User:	DR ASMAH HANIM HAMDAN
Date Deposited:	05 Jul 2021 15:55
Last Modified:	06 Apr 2022 09:36
URI:	http://irep.iium.edu.my/id/eprint/90519

Actions (login required)

View Item